全文获取类型
| 收费全文 | 402篇 |
| 免费 | 10篇 |
| 国内免费 | 11篇 |
专业分类
| 耳鼻咽喉 | 2篇 |
| 儿科学 | 10篇 |
| 妇产科学 | 4篇 |
| 基础医学 | 53篇 |
| 口腔科学 | 12篇 |
| 临床医学 | 22篇 |
| 内科学 | 90篇 |
| 皮肤病学 | 21篇 |
| 神经病学 | 11篇 |
| 特种医学 | 68篇 |
| 外科学 | 36篇 |
| 综合类 | 10篇 |
| 预防医学 | 5篇 |
| 眼科学 | 9篇 |
| 药学 | 45篇 |
| 中国医学 | 3篇 |
| 肿瘤学 | 22篇 |
出版年
| 2021年 | 3篇 |
| 2020年 | 7篇 |
| 2019年 | 3篇 |
| 2018年 | 4篇 |
| 2017年 | 6篇 |
| 2016年 | 5篇 |
| 2015年 | 5篇 |
| 2014年 | 8篇 |
| 2013年 | 11篇 |
| 2012年 | 11篇 |
| 2011年 | 9篇 |
| 2010年 | 19篇 |
| 2009年 | 21篇 |
| 2008年 | 7篇 |
| 2007年 | 12篇 |
| 2006年 | 18篇 |
| 2005年 | 12篇 |
| 2004年 | 13篇 |
| 2003年 | 11篇 |
| 2002年 | 8篇 |
| 2001年 | 12篇 |
| 2000年 | 4篇 |
| 1999年 | 7篇 |
| 1998年 | 22篇 |
| 1997年 | 16篇 |
| 1996年 | 20篇 |
| 1995年 | 16篇 |
| 1994年 | 12篇 |
| 1993年 | 10篇 |
| 1992年 | 5篇 |
| 1991年 | 6篇 |
| 1990年 | 7篇 |
| 1989年 | 15篇 |
| 1988年 | 9篇 |
| 1987年 | 7篇 |
| 1986年 | 8篇 |
| 1985年 | 12篇 |
| 1984年 | 2篇 |
| 1983年 | 5篇 |
| 1982年 | 8篇 |
| 1981年 | 3篇 |
| 1980年 | 3篇 |
| 1978年 | 3篇 |
| 1977年 | 3篇 |
| 1976年 | 4篇 |
| 1975年 | 3篇 |
| 1973年 | 1篇 |
| 1972年 | 1篇 |
| 1971年 | 1篇 |
| 1969年 | 1篇 |
排序方式： 共有423条查询结果，搜索用时 0 毫秒
41.
The effect of a zinc metalloprotease from Serratia marcescens on platelet surface glycoproteins (GP) Ib and V was analyzed. Increasing protease treatments caused progressive loss of GP Ib with appearance of the major fragment, glycocalicin, in the supernatant solution. No GP V was detected in the supernatant solution, and protease-pretreated platelets had the same capacity as control platelets to release fragment 1 of GP V in response to thrombin. The Serratia protease- pretreated platelets did show the lag before thrombin-induced dense granule secretion, characteristic of platelets modified by pretreatment with other nonstimulating proteases. Treatment with Serratia protease gives the only demonstrated selective loss of GP Ib without apparent effect on GP V. It suggests that GP V (1) does not depend on GP Ib for its association with platelets and (2) is not the substrate for protease modification of platelet function. 相似文献
42.
Weisenburger DD; Gordon BG; Vose JM; Bast MA; Chan WC; Greiner TC; Anderson JR; Sanger WG 《Blood》1996,87(9):3860-3868
Primary CD30(Ki-1)-positive anaplastic large-cell lymphoma (ALCL) is considered by some to be a distinct clinicopathologic entity associated with the t(2;5) (p23;q35). However, the specificity of t(2;5) for ALCL has not been carefully studied. Therefore, we performed a detailed analysis of all cases of ALCL with abnormal cytogenetics results in the Nebraska Lymphoma Study Group registry, as well as all other cases of non-Hodgkin's lymphoma with t(2;5) in the registry. We found the t(2;5) in only five of 10 cases of ALCL, four of whom were young patients. However, we also found the t(2;5) in 11 other cases of nonanaplastic lymphoma, including eight children with typical peripheral T-cell lymphomas of various types. The t(2;5) was also found in three older adults with B-cell lymphomas of various types. Thus, the t(2;5) was not specific for CD30+ ALCL. However, t(2;5) may define a clinicopathologic entity in children and young adults characterized by variable morphologies with a T-cell or indeterminate phenotype, CD30-positivity, nodal disease with frequent extranodal involvement, advanced stage, and an excellent response to therapy, including bone marrow transplantation for relapsed disease. The clinical relevance of the t(2;5) in older patients requires further study. 相似文献
43.
44.
The skin thinning effect of discontinuous topical clobetasol-17-propionate applications was tested in human volunteers. Application frequencies were daily (1/0), every third day (1/2), every fifth day (1/4), every seventh day (1/6) and every ninth day (1/8). Clobetasol-17-propionate was administered topically under occlusion for 1 h. The treatment period was 41 days. There were no differences of the skin thinning effect of daily and 1/2 administration. The skin thinning effect of 1/4, 1/6 and 1/8 was smaller but also significant compared to controls. The curves demonstrating skin thinning effects initially were dropping off and reached a plateau within about 2 weeks. After finishing application, skin thickness normalized within 2 weeks. Because of these findings, a treatment interval of 3 days is discussed as therapeutically efficient. 相似文献
45.
Jonathan TC Liu Sarah SL Chow Richard Colling Michelle R Downes Xavier Farré Peter Humphrey Andrew Janowczyk Tuomas Mirtti Clare Verrill Inti Zlobec Lawrence D True 《The Journal of Pathology: Clinical Research》2024,10(1):e347
In recent years, technological advances in tissue preparation, high-throughput volumetric microscopy, and computational infrastructure have enabled rapid developments in nondestructive 3D pathology, in which high-resolution histologic datasets are obtained from thick tissue specimens, such as whole biopsies, without the need for physical sectioning onto glass slides. While 3D pathology generates massive datasets that are attractive for automated computational analysis, there is also a desire to use 3D pathology to improve the visual assessment of tissue histology. In this perspective, we discuss and provide examples of potential advantages of 3D pathology for the visual assessment of clinical specimens and the challenges of dealing with large 3D datasets (of individual or multiple specimens) that pathologists have not been trained to interpret. We discuss the need for artificial intelligence triaging algorithms and explainable analysis methods to assist pathologists or other domain experts in the interpretation of these novel, often complex, large datasets. 相似文献
46.
Cone beam computed tomography is widely used in dentistry. Incidental findings are common, with many requiring intervention or monitoring. We present a rare case of previously undiagnosed, asymptomatic multiple myeloma first identified incidentally on cone beam computed tomography and panoramic radiography. This case highlights the diverse range of lesions that may appear on cone beam computed tomography and the importance of radiologic interpretation. 相似文献
47.
48.
S Grover PS Murthy PK Kar V Tewari TC Shivyogi R Manjunath 《Medical Journal Armed Forces India》2006,62(4):375-377
49.
50.